Rubin M - Search Results

1

Nontruncated amino-terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivation.

Caron P, Simonds WF, Maiza JC, Rubin M, Cantor T, Rousseau L, Bilezikian JP, Souberbielle JC, D'Amour P. Caron P, et al. Among authors: rubin m. Clin Endocrinol (Oxf). 2011 Jun;74(6):694-8. doi: 10.1111/j.1365-2265.2011.04021.x. Clin Endocrinol (Oxf). 2011. PMID: 21521290 Free PMC article.

2

Tc99m-sestamibi uptake in osteitis fibrosa cystica simulating metastatic bone disease.

Rubin MR, Livolsi VA, Bandeira F, Caldas G, Bilezikian JP. Rubin MR, et al. J Clin Endocrinol Metab. 2001 Nov;86(11):5138-41. doi: 10.1210/jcem.86.11.7994. J Clin Endocrinol Metab. 2001. PMID: 11701666 No abstract available.

3

The anabolic effects of parathyroid hormone.

Rubin MR, Cosman F, Lindsay R, Bilezikian JP. Rubin MR, et al. Osteoporos Int. 2002;13(4):267-77. doi: 10.1007/s001980200026. Osteoporos Int. 2002. PMID: 12030541 Review. No abstract available.

4

The potential of parathyroid hormone as a therapy for osteoporosis.

Rubin MR, Bilezikian JP. Rubin MR, et al. Int J Fertil Womens Med. 2002 May-Jun;47(3):103-15. Int J Fertil Womens Med. 2002. PMID: 12081255 Review.

5

New anabolic therapies in osteoporosis.

Rubin MR, Bilezikian JP. Rubin MR, et al. Curr Opin Rheumatol. 2002 Jul;14(4):433-40. doi: 10.1097/00002281-200207000-00018. Curr Opin Rheumatol. 2002. PMID: 12118181 Review.

6

Clinical review 151: The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence.

Rubin MR, Bilezikian JP. Rubin MR, et al. J Clin Endocrinol Metab. 2002 Sep;87(9):4033-41. doi: 10.1210/jc.2002-012101. J Clin Endocrinol Metab. 2002. PMID: 12213840 Review. No abstract available.

7

New anabolic therapies in osteoporosis.

Rubin MR, Bilezikian JP. Rubin MR, et al. Endocrinol Metab Clin North Am. 2003 Mar;32(1):285-307. doi: 10.1016/s0889-8529(02)00056-7. Endocrinol Metab Clin North Am. 2003. PMID: 12699304 Review.

8

Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures.

Siris ES, Bilezikian JP, Rubin MR, Black DM, Bockman RS, Bone HG, Hochberg MC, McClung MR, Schnitzer TJ. Siris ES, et al. Among authors: rubin mr. J Clin Endocrinol Metab. 2003 Aug;88(8):3482-6. doi: 10.1210/jc.2003-030568. J Clin Endocrinol Metab. 2003. PMID: 12915621 Review.

9

The anabolic effects of parathyroid hormone therapy.

Rubin MR, Bilezikian JP. Rubin MR, et al. Clin Geriatr Med. 2003 May;19(2):415-32. doi: 10.1016/s0749-0690(02)00074-5. Clin Geriatr Med. 2003. PMID: 12916294 Review.

10

Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.

Khan AA, Bilezikian JP, Kung AW, Ahmed MM, Dubois SJ, Ho AY, Schussheim D, Rubin MR, Shaikh AM, Silverberg SJ, Standish TI, Syed Z, Syed ZA. Khan AA, et al. Among authors: rubin mr. J Clin Endocrinol Metab. 2004 Jul;89(7):3319-25. doi: 10.1210/jc.2003-030908. J Clin Endocrinol Metab. 2004. PMID: 15240609 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,567 results

Search Page

Filters